APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Corona Rapid Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Corona Rapid Test Market Outlook and Growth Opportunities 2026

Report ID 17442384054 July 2026218 pages

Choose your research edition.

Industry ResearchCorona Rapid Test Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Corona Rapid Test Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Corona Rapid Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Corona Rapid Test Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Corona Rapid Test Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Corona Rapid Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Corona Rapid Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Corona Rapid Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Corona Rapid Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Corona Rapid Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Corona Rapid Test market include 3M, Academia Sinica, Access Bio, Inc., Altona Diagnostics, AmonMed Biotechnology, Becton, Dickinson & Company, Beijing Tigsun Diagnostics, Biomaxima and BioMednomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Corona Rapid Test market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Corona Rapid Test and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Corona Rapid Test sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Corona Rapid Test market size, projected growth trends, production technologies, key applications, and end-use industries.

Corona Rapid Test Segment by Company

3M

Academia Sinica

Access Bio, Inc.

Altona Diagnostics

AmonMed Biotechnology

Becton, Dickinson & Company

Beijing Tigsun Diagnostics

Biomaxima

BioMednomics

Blink Science

Canary Health Technologies

Coronalab

CTK Biotech

Ellume Health

GenSpeed Biotech

Getein Biotech

Hememics Biotechnologies

Hunan Lituo Biotechnology

IdentifySensors Biologics LLC

Kephera Diagnostics

L&H Biotech Limited

Laipac Technology

MyLab

Mylab Discovery Solutions Pvt

Sensing Self

Vivacheck Lab

Wondfo

Hangzhou Biotest Biotech

Abbott

Corona Rapid Test Segment by Type

Nasal Cavity

Saliva

Corona Rapid Test Segment by Application

Medical

Research

Corona Rapid Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Corona Rapid Test status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Corona Rapid Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Corona Rapid Test significant trends, drivers, influence factors in global and regions.

6. To analyze Corona Rapid Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corona Rapid Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Corona Rapid Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corona Rapid Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Corona Rapid Test market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Corona Rapid Test industry.

Chapter 3: Detailed analysis of Corona Rapid Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Corona Rapid Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Corona Rapid Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Corona Rapid Test Industry Trends Table 2. Corona Rapid Test Industry Drivers Table 3. Corona Rapid Test Industry Opportunities and Challenges Table 4. Corona Rapid Test Industry Restraints Table 5. Global Corona Rapid Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Corona Rapid Test Revenue Share by Company (2021-2026) Table 7. Global Corona Rapid Test Sales Volume by Company (k units) & (2021-2026) Table 8. Global Corona Rapid Test Sales Volume Share by Company (2021-2026) Table 9. Global Corona Rapid Test Average Price (USD/unit) of Company (2021-2026) Table 10. Global Corona Rapid Test Company Ranking, (2024-2026) & (USD Million) Table 11. Global Corona Rapid Test Key Company Manufacturing Base & Headquarters Table 12. Global Corona Rapid Test Company, Product Type & Application Table 13. Global Corona Rapid Test Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Corona Rapid Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Cavity Table 18. Significant Companies of Saliva Table 19. Global Corona Rapid Test Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Corona Rapid Test Sales Volume by Type (2021-2026) & (k units) Table 21. Global Corona Rapid Test Sales Volume by Type (2027-2032) & (k units) Table 22. Global Corona Rapid Test Sales Volume Share by Type (2021-2026) Table 23. Global Corona Rapid Test Sales Volume Share by Type (2027-2032) Table 24. Global Corona Rapid Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Corona Rapid Test Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Corona Rapid Test Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Corona Rapid Test Sales Value Share by Type (2021-2026) Table 28. Global Corona Rapid Test Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Table 30. Significant Companies of Research Table 31. Global Corona Rapid Test Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Corona Rapid Test Sales Volume by Application (2021-2026) & (k units) Table 33. Global Corona Rapid Test Sales Volume by Application (2027-2032) & (k units) Table 34. Global Corona Rapid Test Sales Volume Share by Application (2021-2026) Table 35. Global Corona Rapid Test Sales Volume Share by Application (2027-2032) Table 36. Global Corona Rapid Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Corona Rapid Test Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Corona Rapid Test Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Corona Rapid Test Sales Value Share by Application (2021-2026) Table 40. Global Corona Rapid Test Sales Value Share by Application (2027-2032) Table 41. Global Corona Rapid Test Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Corona Rapid Test Sales by Region (2021-2026) & (k units) Table 43. Global Corona Rapid Test Sales Market Share by Region (2021-2026) Table 44. Global Corona Rapid Test Sales by Region (2027-2032) & (k units) Table 45. Global Corona Rapid Test Sales Market Share by Region (2027-2032) Table 46. Global Corona Rapid Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Corona Rapid Test Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Corona Rapid Test Sales Value Share by Region (2021-2026) Table 49. Global Corona Rapid Test Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Corona Rapid Test Sales Value Share by Region (2027-2032) Table 51. Global Corona Rapid Test Market Average Price (USD/unit) by Region (2021-2026) Table 52. Global Corona Rapid Test Market Average Price (USD/unit) by Region (2027-2032) Table 53. Global Corona Rapid Test Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Corona Rapid Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Corona Rapid Test Sales by Country (2021-2026) & (k units) Table 56. Global Corona Rapid Test Sales Market Share by Country (2021-2026) Table 57. Global Corona Rapid Test Sales by Country (2027-2032) & (k units) Table 58. Global Corona Rapid Test Sales Market Share by Country (2027-2032) Table 59. Global Corona Rapid Test Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Corona Rapid Test Sales Value Market Share by Country (2021-2026) Table 61. Global Corona Rapid Test Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Corona Rapid Test Sales Value Market Share by Country (2027-2032) Table 63. 3M Company Information Table 64. 3M Business Overview Table 65. 3M Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. 3M Corona Rapid Test Product Portfolio Table 67. 3M Recent Development Table 68. Academia Sinica Company Information Table 69. Academia Sinica Business Overview Table 70. Academia Sinica Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Academia Sinica Corona Rapid Test Product Portfolio Table 72. Academia Sinica Recent Development Table 73. Access Bio, Inc. Company Information Table 74. Access Bio, Inc. Business Overview Table 75. Access Bio, Inc. Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Access Bio, Inc. Corona Rapid Test Product Portfolio Table 77. Access Bio, Inc. Recent Development Table 78. Altona Diagnostics Company Information Table 79. Altona Diagnostics Business Overview Table 80. Altona Diagnostics Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Altona Diagnostics Corona Rapid Test Product Portfolio Table 82. Altona Diagnostics Recent Development Table 83. AmonMed Biotechnology Company Information Table 84. AmonMed Biotechnology Business Overview Table 85. AmonMed Biotechnology Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. AmonMed Biotechnology Corona Rapid Test Product Portfolio Table 87. AmonMed Biotechnology Recent Development Table 88. Becton, Dickinson & Company Company Information Table 89. Becton, Dickinson & Company Business Overview Table 90. Becton, Dickinson & Company Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Becton, Dickinson & Company Corona Rapid Test Product Portfolio Table 92. Becton, Dickinson & Company Recent Development Table 93. Beijing Tigsun Diagnostics Company Information Table 94. Beijing Tigsun Diagnostics Business Overview Table 95. Beijing Tigsun Diagnostics Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Beijing Tigsun Diagnostics Corona Rapid Test Product Portfolio Table 97. Beijing Tigsun Diagnostics Recent Development Table 98. Biomaxima Company Information Table 99. Biomaxima Business Overview Table 100. Biomaxima Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Biomaxima Corona Rapid Test Product Portfolio Table 102. Biomaxima Recent Development Table 103. BioMednomics Company Information Table 104. BioMednomics Business Overview Table 105. BioMednomics Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. BioMednomics Corona Rapid Test Product Portfolio Table 107. BioMednomics Recent Development Table 108. Blink Science Company Information Table 109. Blink Science Business Overview Table 110. Blink Science Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Blink Science Corona Rapid Test Product Portfolio Table 112. Blink Science Recent Development Table 113. Canary Health Technologies Company Information Table 114. Canary Health Technologies Business Overview Table 115. Canary Health Technologies Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Canary Health Technologies Corona Rapid Test Product Portfolio Table 117. Canary Health Technologies Recent Development Table 118. Coronalab Company Information Table 119. Coronalab Business Overview Table 120. Coronalab Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Coronalab Corona Rapid Test Product Portfolio Table 122. Coronalab Recent Development Table 123. CTK Biotech Company Information Table 124. CTK Biotech Business Overview Table 125. CTK Biotech Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. CTK Biotech Corona Rapid Test Product Portfolio Table 127. CTK Biotech Recent Development Table 128. Ellume Health Company Information Table 129. Ellume Health Business Overview Table 130. Ellume Health Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Ellume Health Corona Rapid Test Product Portfolio Table 132. Ellume Health Recent Development Table 133. GenSpeed Biotech Company Information Table 134. GenSpeed Biotech Business Overview Table 135. GenSpeed Biotech Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. GenSpeed Biotech Corona Rapid Test Product Portfolio Table 137. GenSpeed Biotech Recent Development Table 138. Getein Biotech Company Information Table 139. Getein Biotech Business Overview Table 140. Getein Biotech Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Getein Biotech Corona Rapid Test Product Portfolio Table 142. Getein Biotech Recent Development Table 143. Hememics Biotechnologies Company Information Table 144. Hememics Biotechnologies Business Overview Table 145. Hememics Biotechnologies Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Hememics Biotechnologies Corona Rapid Test Product Portfolio Table 147. Hememics Biotechnologies Recent Development Table 148. Hunan Lituo Biotechnology Company Information Table 149. Hunan Lituo Biotechnology Business Overview Table 150. Hunan Lituo Biotechnology Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Hunan Lituo Biotechnology Corona Rapid Test Product Portfolio Table 152. Hunan Lituo Biotechnology Recent Development Table 153. IdentifySensors Biologics LLC Company Information Table 154. IdentifySensors Biologics LLC Business Overview Table 155. IdentifySensors Biologics LLC Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. IdentifySensors Biologics LLC Corona Rapid Test Product Portfolio Table 157. IdentifySensors Biologics LLC Recent Development Table 158. Kephera Diagnostics Company Information Table 159. Kephera Diagnostics Business Overview Table 160. Kephera Diagnostics Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Kephera Diagnostics Corona Rapid Test Product Portfolio Table 162. Kephera Diagnostics Recent Development Table 163. L&H Biotech Limited Company Information Table 164. L&H Biotech Limited Business Overview Table 165. L&H Biotech Limited Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. L&H Biotech Limited Corona Rapid Test Product Portfolio Table 167. L&H Biotech Limited Recent Development Table 168. Laipac Technology Company Information Table 169. Laipac Technology Business Overview Table 170. Laipac Technology Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Laipac Technology Corona Rapid Test Product Portfolio Table 172. Laipac Technology Recent Development Table 173. MyLab Company Information Table 174. MyLab Business Overview Table 175. MyLab Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. MyLab Corona Rapid Test Product Portfolio Table 177. MyLab Recent Development Table 178. Mylab Discovery Solutions Pvt Company Information Table 179. Mylab Discovery Solutions Pvt Business Overview Table 180. Mylab Discovery Solutions Pvt Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. Mylab Discovery Solutions Pvt Corona Rapid Test Product Portfolio Table 182. Mylab Discovery Solutions Pvt Recent Development Table 183. Sensing Self Company Information Table 184. Sensing Self Business Overview Table 185. Sensing Self Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. Sensing Self Corona Rapid Test Product Portfolio Table 187. Sensing Self Recent Development Table 188. Vivacheck Lab Company Information Table 189. Vivacheck Lab Business Overview Table 190. Vivacheck Lab Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 191. Vivacheck Lab Corona Rapid Test Product Portfolio Table 192. Vivacheck Lab Recent Development Table 193. Wondfo Company Information Table 194. Wondfo Business Overview Table 195. Wondfo Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 196. Wondfo Corona Rapid Test Product Portfolio Table 197. Wondfo Recent Development Table 198. Hangzhou Biotest Biotech Company Information Table 199. Hangzhou Biotest Biotech Business Overview Table 200. Hangzhou Biotest Biotech Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 201. Hangzhou Biotest Biotech Corona Rapid Test Product Portfolio Table 202. Hangzhou Biotest Biotech Recent Development Table 203. Abbott Company Information Table 204. Abbott Business Overview Table 205. Abbott Corona Rapid Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 206. Abbott Corona Rapid Test Product Portfolio Table 207. Abbott Recent Development Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Corona Rapid Test Distributors List Table 211. Corona Rapid Test Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Corona Rapid Test Product Image Figure 2. Global Corona Rapid Test Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 4. Global Corona Rapid Test Sales (2021-2032) & (k units) Figure 5. Global Corona Rapid Test Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Corona Rapid Test Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Cavity Image Figure 10. Saliva Image Figure 11. Global Corona Rapid Test Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Corona Rapid Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Corona Rapid Test Sales Volume Share by Type (2021-2032) Figure 14. Global Corona Rapid Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Corona Rapid Test Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Corona Rapid Test Sales Value Share by Type (2021-2032) Figure 17. Medical Image Figure 18. Research Image Figure 19. Global Corona Rapid Test Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Corona Rapid Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Corona Rapid Test Sales Volume Share by Application (2021-2032) Figure 22. Global Corona Rapid Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Corona Rapid Test Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Corona Rapid Test Sales Value Share by Application (2021-2032) Figure 25. Global Corona Rapid Test Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Corona Rapid Test Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Corona Rapid Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Corona Rapid Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 30. North America Corona Rapid Test Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Corona Rapid Test Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Corona Rapid Test Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 36. South America Corona Rapid Test Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Corona Rapid Test Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Corona Rapid Test Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Corona Rapid Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Corona Rapid Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Corona Rapid Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Corona Rapid Test Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Corona Rapid Test Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Cavity
  • Saliva
Applications
  • Medical
  • Research
Companies covered
  • 3M
  • Academia Sinica
  • Access Bio, Inc.
  • Altona Diagnostics
  • AmonMed Biotechnology
  • Becton, Dickinson & Company
  • Beijing Tigsun Diagnostics
  • Biomaxima
  • BioMednomics
  • Blink Science
  • Canary Health Technologies
  • Coronalab
  • CTK Biotech
  • Ellume Health
  • GenSpeed Biotech
  • Getein Biotech
  • Hememics Biotechnologies
  • Hunan Lituo Biotechnology
  • IdentifySensors Biologics LLC
  • Kephera Diagnostics
  • L&H Biotech Limited
  • Laipac Technology
  • MyLab
  • Mylab Discovery Solutions Pvt
  • Sensing Self
  • Vivacheck Lab
  • Wondfo
  • Hangzhou Biotest Biotech
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Corona Rapid Test Sales Value (2021-2032)
  4. 1.2.2 Global Corona Rapid Test Sales Volume (2021-2032)
  5. 1.2.3 Global Corona Rapid Test Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Corona Rapid Test Market Dynamics
  1. 2.1 Corona Rapid Test Industry Trends
  2. 2.2 Corona Rapid Test Industry Drivers
  3. 2.3 Corona Rapid Test Industry Opportunities and Challenges
  4. 2.4 Corona Rapid Test Industry Restraints
3 Corona Rapid Test Market by Company
  1. 3.1 Global Corona Rapid Test Company Revenue Ranking in 2025
  2. 3.2 Global Corona Rapid Test Revenue by Company (2021-2026)
  3. 3.3 Global Corona Rapid Test Sales Volume by Company (2021-2026)
  4. 3.4 Global Corona Rapid Test Average Price by Company (2021-2026)
  5. 3.5 Global Corona Rapid Test Company Ranking (2024-2026)
  6. 3.6 Global Corona Rapid Test Company Manufacturing Base and Headquarters
  7. 3.7 Global Corona Rapid Test Company Product Type and Application
  8. 3.8 Global Corona Rapid Test Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Corona Rapid Test Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Corona Rapid Test Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Corona Rapid Test Market by Type
  1. 4.1 Corona Rapid Test Type Introduction
  2. 4.1.1 Nasal Cavity
  3. 4.1.2 Saliva
  4. 4.2 Global Corona Rapid Test Sales Volume by Type
  5. 4.2.1 Global Corona Rapid Test Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Corona Rapid Test Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Corona Rapid Test Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Corona Rapid Test Sales Value by Type
  9. 4.3.1 Global Corona Rapid Test Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Corona Rapid Test Sales Value by Type (2021-2032)
  11. 4.3.3 Global Corona Rapid Test Sales Value Share by Type (2021-2032)
5 Corona Rapid Test Market by Application
  1. 5.1 Corona Rapid Test Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Research
  4. 5.2 Global Corona Rapid Test Sales Volume by Application
  5. 5.2.1 Global Corona Rapid Test Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Corona Rapid Test Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Corona Rapid Test Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Corona Rapid Test Sales Value by Application
  9. 5.3.1 Global Corona Rapid Test Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Corona Rapid Test Sales Value by Application (2021-2032)
  11. 5.3.3 Global Corona Rapid Test Sales Value Share by Application (2021-2032)
6 Corona Rapid Test Regional Sales and Value Analysis
  1. 6.1 Global Corona Rapid Test Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Corona Rapid Test Sales by Region (2021-2032)
  3. 6.2.1 Global Corona Rapid Test Sales by Region: 2021-2026
  4. 6.2.2 Global Corona Rapid Test Sales by Region (2027-2032)
  5. 6.3 Global Corona Rapid Test Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Corona Rapid Test Sales Value by Region (2021-2032)
  7. 6.4.1 Global Corona Rapid Test Sales Value by Region: 2021-2026
  8. 6.4.2 Global Corona Rapid Test Sales Value by Region (2027-2032)
  9. 6.5 Global Corona Rapid Test Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Corona Rapid Test Sales Value (2021-2032)
  12. 6.6.2 North America Corona Rapid Test Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Corona Rapid Test Sales Value (2021-2032)
  15. 6.7.2 Europe Corona Rapid Test Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Corona Rapid Test Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Corona Rapid Test Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Corona Rapid Test Sales Value (2021-2032)
  21. 6.9.2 South America Corona Rapid Test Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Corona Rapid Test Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Corona Rapid Test Sales Value Share by Country, 2025 VS 2032
7 Corona Rapid Test Country-level Sales and Value Analysis
  1. 7.1 Global Corona Rapid Test Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Corona Rapid Test Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Corona Rapid Test Sales by Country (2021-2032)
  4. 7.3.1 Global Corona Rapid Test Sales by Country (2021-2026)
  5. 7.3.2 Global Corona Rapid Test Sales by Country (2027-2032)
  6. 7.4 Global Corona Rapid Test Sales Value by Country (2021-2032)
  7. 7.4.1 Global Corona Rapid Test Sales Value by Country (2021-2026)
  8. 7.4.2 Global Corona Rapid Test Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Corona Rapid Test Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Corona Rapid Test Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Corona Rapid Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Corona Rapid Test Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Corona Rapid Test Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Corona Rapid Test Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Corona Rapid Test Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Corona Rapid Test Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Corona Rapid Test Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Corona Rapid Test Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Corona Rapid Test Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Corona Rapid Test Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Corona Rapid Test Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Corona Rapid Test Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Corona Rapid Test Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Corona Rapid Test Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Corona Rapid Test Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Corona Rapid Test Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Corona Rapid Test Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Corona Rapid Test Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Corona Rapid Test Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Corona Rapid Test Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Corona Rapid Test Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Corona Rapid Test Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Corona Rapid Test Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Corona Rapid Test Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Corona Rapid Test Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Corona Rapid Test Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Corona Rapid Test Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Corona Rapid Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 3M
  2. 8.1.1 3M Company Information
  3. 8.1.2 3M Business Overview
  4. 8.1.3 3M Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 3M Corona Rapid Test Product Portfolio
  6. 8.1.5 3M Recent Developments
  7. 8.2 Academia Sinica
  8. 8.2.1 Academia Sinica Company Information
  9. 8.2.2 Academia Sinica Business Overview
  10. 8.2.3 Academia Sinica Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Academia Sinica Corona Rapid Test Product Portfolio
  12. 8.2.5 Academia Sinica Recent Developments
  13. 8.3 Access Bio, Inc.
  14. 8.3.1 Access Bio, Inc. Company Information
  15. 8.3.2 Access Bio, Inc. Business Overview
  16. 8.3.3 Access Bio, Inc. Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Access Bio, Inc. Corona Rapid Test Product Portfolio
  18. 8.3.5 Access Bio, Inc. Recent Developments
  19. 8.4 Altona Diagnostics
  20. 8.4.1 Altona Diagnostics Company Information
  21. 8.4.2 Altona Diagnostics Business Overview
  22. 8.4.3 Altona Diagnostics Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Altona Diagnostics Corona Rapid Test Product Portfolio
  24. 8.4.5 Altona Diagnostics Recent Developments
  25. 8.5 AmonMed Biotechnology
  26. 8.5.1 AmonMed Biotechnology Company Information
  27. 8.5.2 AmonMed Biotechnology Business Overview
  28. 8.5.3 AmonMed Biotechnology Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AmonMed Biotechnology Corona Rapid Test Product Portfolio
  30. 8.5.5 AmonMed Biotechnology Recent Developments
  31. 8.6 Becton, Dickinson & Company
  32. 8.6.1 Becton, Dickinson & Company Company Information
  33. 8.6.2 Becton, Dickinson & Company Business Overview
  34. 8.6.3 Becton, Dickinson & Company Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Becton, Dickinson & Company Corona Rapid Test Product Portfolio
  36. 8.6.5 Becton, Dickinson & Company Recent Developments
  37. 8.7 Beijing Tigsun Diagnostics
  38. 8.7.1 Beijing Tigsun Diagnostics Company Information
  39. 8.7.2 Beijing Tigsun Diagnostics Business Overview
  40. 8.7.3 Beijing Tigsun Diagnostics Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Tigsun Diagnostics Corona Rapid Test Product Portfolio
  42. 8.7.5 Beijing Tigsun Diagnostics Recent Developments
  43. 8.8 Biomaxima
  44. 8.8.1 Biomaxima Company Information
  45. 8.8.2 Biomaxima Business Overview
  46. 8.8.3 Biomaxima Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biomaxima Corona Rapid Test Product Portfolio
  48. 8.8.5 Biomaxima Recent Developments
  49. 8.9 BioMednomics
  50. 8.9.1 BioMednomics Company Information
  51. 8.9.2 BioMednomics Business Overview
  52. 8.9.3 BioMednomics Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BioMednomics Corona Rapid Test Product Portfolio
  54. 8.9.5 BioMednomics Recent Developments
  55. 8.10 Blink Science
  56. 8.10.1 Blink Science Company Information
  57. 8.10.2 Blink Science Business Overview
  58. 8.10.3 Blink Science Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Blink Science Corona Rapid Test Product Portfolio
  60. 8.10.5 Blink Science Recent Developments
  61. 8.11 Canary Health Technologies
  62. 8.11.1 Canary Health Technologies Company Information
  63. 8.11.2 Canary Health Technologies Business Overview
  64. 8.11.3 Canary Health Technologies Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Canary Health Technologies Corona Rapid Test Product Portfolio
  66. 8.11.5 Canary Health Technologies Recent Developments
  67. 8.12 Coronalab
  68. 8.12.1 Coronalab Company Information
  69. 8.12.2 Coronalab Business Overview
  70. 8.12.3 Coronalab Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Coronalab Corona Rapid Test Product Portfolio
  72. 8.12.5 Coronalab Recent Developments
  73. 8.13 CTK Biotech
  74. 8.13.1 CTK Biotech Company Information
  75. 8.13.2 CTK Biotech Business Overview
  76. 8.13.3 CTK Biotech Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CTK Biotech Corona Rapid Test Product Portfolio
  78. 8.13.5 CTK Biotech Recent Developments
  79. 8.14 Ellume Health
  80. 8.14.1 Ellume Health Company Information
  81. 8.14.2 Ellume Health Business Overview
  82. 8.14.3 Ellume Health Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Ellume Health Corona Rapid Test Product Portfolio
  84. 8.14.5 Ellume Health Recent Developments
  85. 8.15 GenSpeed Biotech
  86. 8.15.1 GenSpeed Biotech Company Information
  87. 8.15.2 GenSpeed Biotech Business Overview
  88. 8.15.3 GenSpeed Biotech Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 GenSpeed Biotech Corona Rapid Test Product Portfolio
  90. 8.15.5 GenSpeed Biotech Recent Developments
  91. 8.16 Getein Biotech
  92. 8.16.1 Getein Biotech Company Information
  93. 8.16.2 Getein Biotech Business Overview
  94. 8.16.3 Getein Biotech Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Getein Biotech Corona Rapid Test Product Portfolio
  96. 8.16.5 Getein Biotech Recent Developments
  97. 8.17 Hememics Biotechnologies
  98. 8.17.1 Hememics Biotechnologies Company Information
  99. 8.17.2 Hememics Biotechnologies Business Overview
  100. 8.17.3 Hememics Biotechnologies Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Hememics Biotechnologies Corona Rapid Test Product Portfolio
  102. 8.17.5 Hememics Biotechnologies Recent Developments
  103. 8.18 Hunan Lituo Biotechnology
  104. 8.18.1 Hunan Lituo Biotechnology Company Information
  105. 8.18.2 Hunan Lituo Biotechnology Business Overview
  106. 8.18.3 Hunan Lituo Biotechnology Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Hunan Lituo Biotechnology Corona Rapid Test Product Portfolio
  108. 8.18.5 Hunan Lituo Biotechnology Recent Developments
  109. 8.19 IdentifySensors Biologics LLC
  110. 8.19.1 IdentifySensors Biologics LLC Company Information
  111. 8.19.2 IdentifySensors Biologics LLC Business Overview
  112. 8.19.3 IdentifySensors Biologics LLC Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 IdentifySensors Biologics LLC Corona Rapid Test Product Portfolio
  114. 8.19.5 IdentifySensors Biologics LLC Recent Developments
  115. 8.20 Kephera Diagnostics
  116. 8.20.1 Kephera Diagnostics Company Information
  117. 8.20.2 Kephera Diagnostics Business Overview
  118. 8.20.3 Kephera Diagnostics Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Kephera Diagnostics Corona Rapid Test Product Portfolio
  120. 8.20.5 Kephera Diagnostics Recent Developments
  121. 8.21 L&H Biotech Limited
  122. 8.21.1 L&H Biotech Limited Company Information
  123. 8.21.2 L&H Biotech Limited Business Overview
  124. 8.21.3 L&H Biotech Limited Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 L&H Biotech Limited Corona Rapid Test Product Portfolio
  126. 8.21.5 L&H Biotech Limited Recent Developments
  127. 8.22 Laipac Technology
  128. 8.22.1 Laipac Technology Company Information
  129. 8.22.2 Laipac Technology Business Overview
  130. 8.22.3 Laipac Technology Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Laipac Technology Corona Rapid Test Product Portfolio
  132. 8.22.5 Laipac Technology Recent Developments
  133. 8.23 MyLab
  134. 8.23.1 MyLab Company Information
  135. 8.23.2 MyLab Business Overview
  136. 8.23.3 MyLab Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 MyLab Corona Rapid Test Product Portfolio
  138. 8.23.5 MyLab Recent Developments
  139. 8.24 Mylab Discovery Solutions Pvt
  140. 8.24.1 Mylab Discovery Solutions Pvt Company Information
  141. 8.24.2 Mylab Discovery Solutions Pvt Business Overview
  142. 8.24.3 Mylab Discovery Solutions Pvt Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Mylab Discovery Solutions Pvt Corona Rapid Test Product Portfolio
  144. 8.24.5 Mylab Discovery Solutions Pvt Recent Developments
  145. 8.25 Sensing Self
  146. 8.25.1 Sensing Self Company Information
  147. 8.25.2 Sensing Self Business Overview
  148. 8.25.3 Sensing Self Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Sensing Self Corona Rapid Test Product Portfolio
  150. 8.25.5 Sensing Self Recent Developments
  151. 8.26 Vivacheck Lab
  152. 8.26.1 Vivacheck Lab Company Information
  153. 8.26.2 Vivacheck Lab Business Overview
  154. 8.26.3 Vivacheck Lab Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Vivacheck Lab Corona Rapid Test Product Portfolio
  156. 8.26.5 Vivacheck Lab Recent Developments
  157. 8.27 Wondfo
  158. 8.27.1 Wondfo Company Information
  159. 8.27.2 Wondfo Business Overview
  160. 8.27.3 Wondfo Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Wondfo Corona Rapid Test Product Portfolio
  162. 8.27.5 Wondfo Recent Developments
  163. 8.28 Hangzhou Biotest Biotech
  164. 8.28.1 Hangzhou Biotest Biotech Company Information
  165. 8.28.2 Hangzhou Biotest Biotech Business Overview
  166. 8.28.3 Hangzhou Biotest Biotech Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 Hangzhou Biotest Biotech Corona Rapid Test Product Portfolio
  168. 8.28.5 Hangzhou Biotest Biotech Recent Developments
  169. 8.29 Abbott
  170. 8.29.1 Abbott Company Information
  171. 8.29.2 Abbott Business Overview
  172. 8.29.3 Abbott Corona Rapid Test Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 Abbott Corona Rapid Test Product Portfolio
  174. 8.29.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Corona Rapid Test Value Chain Analysis
  2. 9.1.1 Corona Rapid Test Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Corona Rapid Test Sales Mode & Process
  6. 9.2 Corona Rapid Test Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Corona Rapid Test Distributors
  9. 9.2.3 Corona Rapid Test Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst